Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies - Top-Institutions - MDSpire

Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies

  • By

  • Gonzalo S Nido

  • Martina Castelli

  • Sepideh Mostafavi

  • Anna Rubiolo

  • Omnia Shadad

  • Guido Alves

  • Ole-Bjørn Tysnes

  • Irene H Flønes

  • Christian Dölle

  • Charalampos Tzoulis

  • November 15, 2024

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, MA

    Key Differentiators

    • Neurodegenerative Disease
    • Genomics
    • Single-cell Transcriptomics

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neurodegenerative Disorders
    • Molecular Neuroscience

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neuroscience
    • Neurodegeneration
    • Genetics

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neurodegenerative Disease Research
    • Pathology

  • #5

    Massachusetts General Hospital (MGH) - Center for Genomic Medicine
    Massachusetts General Hospital (MGH) - Center for Genomic Medicine

    Boston, MA

    Key Differentiators

    • Genomics
    • Neurodegenerative Diseases
    • Molecular Biology

Original Source(s)

Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies

  • by Gonzalo S Nido, Martina Castelli, Sepideh Mostafavi, Anna Rubiolo, Omnia Shadad, Guido Alves, Ole-Bjørn Tysnes, Irene H Flønes, Christian Dölle, Charalampos Tzoulis

  • November 15, 2024

Related Content

Commentary: Efficacy and safety of magnetic resonance-guided focused ultrasound for Parkinson's disease: a systematic review and meta-analysis

Influence of Genetic Predisposition and Environmental Factors on Dementia with Lewy Bodies: Intersecting Pathogenic Mechanisms

This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

  • May 18, 2026

  • 7 min